Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

48.47 +1.01 (+2.13%)
Streaming Delayed Price Updated: 11:34 AM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback
Hims & Hers stock dipped after Novo Nordisk pulled back its partnership for a weight loss drug distribution, though that may not mean much. 
Via MarketBeat
EXCLUSIVE: 2025's First Half Most-Searched Tickers On Benzinga Pro — Where Do Nvidia, Tesla, Apple Stock Rank?
A look at the top 20 most-searched tickers on Benzinga Pro for the first six months of 2025. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Best Stocks to Buy: Hims & Hers Stock vs. UnitedHealth Stock
Via The Motley Fool
After Its Biggest Drop Ever...Is HIMS A Buy?
Via Benzinga
Is Hims & Hers Stock in Trouble?
Via The Motley Fool
Topics Supply Chain
Where Will Hims & Hers Stock Be in 2030?
Via The Motley Fool
EXCLUSIVE: June's 20 Most-Searched Tickers On Benzinga Pro — Where Do CoreWeave, Nvidia, Apple Stock Rank?
A look at the top 20 most-searched stock tickers for the month of June on Benzinga Pro. 
Via Benzinga
Amazon Wants More Power
Amazon's latest data center will reportedly require the same amount of electricity as 1 million homes. 
Via The Motley Fool
Topics Artificial Intelligence
Great News for Hims & Hers Stock Investors
Via The Motley Fool
Circle Internet, Hims & Hers Health And CoreWeave Are Among Top 10 Large Cap Losers Last Week (June 23-27): Are The Others In Your Portfolio?
Last week's worst performers include CRCL, HIMS, VG, QXO, CRWV, DUOL, EQIX, EQNR, CF, and EC. Are they in your portfolio? 
Via Benzinga
Benzinga Bulls And Bears: Nvidia, Micron, HIMS — And Markets Soar On Mideast And Tariff Relief
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
Hims & Hers Stock Investors Need to Know This Before Buying or Selling This Growth Stock
Via The Motley Fool
Hims & Hers Stock Financial Analysis Following Huge Stock Price Crash
Via The Motley Fool
Stocks making big moves this week: Torrid, Provident Financial Services, Bumble, Coinbase, and Hims & Hers Health
Check out the companies making headlines this week: 
Via StockStory
Topics Workforce
Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover?
The stock's market-beating momentum has come crashing to a halt, following shocking allegations from one of the world's largest pharmaceutical companies. 
Via The Motley Fool
Topics Intellectual Property
Massive News for Hims & Hers Stock Investors!
Via The Motley Fool
Down Over 30%, What's Going on With Hims & Hers stock?
Via The Motley Fool
2 Volatile Stocks Worth Your Attention and 1 to Turn Down
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
Via StockStory
This Weight Loss Partnership Was a Short One
Via The Motley Fool
Topics Economy
Why Is Hims & Hers Health (HIMS) Stock Soaring Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 12.1% in the afternoon session after the company's CEO stated that it will continue to offer cheaper, compounded versions of GLP-1... 
Via StockStory
Topics Artificial Intelligence
What's Going On With Hims & Hers Health Stock Today?
Hims & Hers Health Inc. (NYSE: HIMS) shares are trading higher Thursday. The stock appears to be bouncing back a bit after selling off to start the week. Here's a look at what you need to know. 
Via Benzinga
Behind the Scenes of Hims & Hers Health's Latest Options Trends
Via Benzinga
Why Hims & Hers Stock Is Crashing, and Is It a Buying Opportunity?
Via The Motley Fool
4 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Hims & Hers CEO Says 'No Way In Hell We're Gonna Cave On' Selling Compounded Obesity Drugs After Novo Nordisk Breakup
Truist warned that Hims faces renewed litigation risk after Novo's exit, which could create a prolonged legal overhang on the stock. 
Via Stocktwits
Topics Law Enforcement Lawsuit
HIMS Crashes On Novo GLP-1 Fallout: Buy The Dip Or Bail?
Telehealth company Hims & Hers (HIMS) saw a 34% stock drop after Novo Nordisk (NVO) ended their relationship. Investors must decide if it's a buying opportunity or a warning sign for the industry. 
Via Benzinga
Why Hims & Hers Stock Could Be a Multi-Bagger in the Making
Hims & Hers stock keeps giving investors more reasons to buy, and has all the right factors to turn it into a potential multi-bagger investment. 
Via MarketBeat
Topics Economy
Why Did Hims and Hers Stock Crash on Monday?
Via The Motley Fool
Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.